Skip to main content

Strike Force Operations

Newark Strike Force

Newark Strike Force

Since its inception in 2018, the Newark Strike Force has had tremendous success investigating and prosecuting a variety of health care fraud related schemes involving prescription drugs, telemedicine, diagnostic testing, durable medical equipment; as well as opioid diversion schemes involving providers who are unlawfully dispensing and distributing controlled substances.

The Newark Strike Force is a leader in investigations and prosecutions related to telemedicine schemes. To date, the Newark Strike Force has charged laboratory owners, marketers, telemedicine company owners, and medical professionals for their roles in the submission of false and fraudulent claims to Medicare arising out of purported telemedicine referrals. Recently, the Newark Strike Force obtained a trial conviction against a doctor who falsely and fraudulently billed Medicare for allergy tests, among other things.

Together with federal and state law enforcement partners, Newark Strike Force prosecutors work to increase accountability in the health care industry by decreasing the presence of fraudulent providers; and to combat the opioid crisis by identifying and dismantling opioid diversion schemes.

The Newark Strike Force regularly participates in national and regional fraud enforcement actions, including the 2022 COVID-19 Enforcement Action; the 2022 Opioid Enforcement Action; the 2021 COVID-19 Enforcement Action; 2021 National Health Care Fraud Enforcement Action; the 2020 National Health Care Fraud and Opioid Enforcement Action; the 2019 Northeast Regional Enforcement Action; and the 2019 Operation Brace Yourself Enforcement Action.

See below for more information on some of the cases prosecuted by the Newark Strike Force. For more information, please contact Acting Assistant Chief Debra Jaroslawicz.

Updated September 26, 2023